Regeneron, Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent Injection Fully Enrolled
November 24, 2015 at 04:21 AM EST
Regeneron Pharmaceuticals, Inc.(NASDAQ: REGN) and Sanofi (NYSE: SNY) today announced that the companies have completed enrollment ...
